Project Grant HT94252310309
Award Date 5/1/23
Completion Date 4/30/26
Dollars Obligated $725K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
- The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
- This federal Project Grant award of $749,378.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research by the Trustees of Indiana University, doing business as Indiana University, to investigate the systemic administration of STO-609 to prevent post-traumatic osteoarthritis in a translational porcine intraarticular fracture model. The project will run from August 1, 2025 to July 31, 2028. Indiana University, a prominent public...
- The Trustees of Indiana University were awarded a $3,930,678 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2024 to target replication stress in pediatric and young adult osteosarcoma. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award...
- The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
- The Defense Health Agency awarded a $435,782.00 Project Grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from January 1, 2025 to December 31, 2027, will support research to explore the effects of tranexamic acid (TXA) on the pulmonary endothelium after thoracic trauma, with the goal of preserving endothelial integrity. As a prominent public research...
- This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
- The Trustees of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis), has been awarded a $1,576,423 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This federal grant, awarded on August 1, 2024, will support research to mitigate therapy resistance by combining CDK4/6 and PI3K/mTOR inhibition in pediatric and adolescent/young adult (AYA) osteosarcoma. The research project aims to develop...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $7,195,717.00 to the Trustees of Indiana University for a research project titled "INTRA-ARTICULAR INJECTION OF AMOBARBITAL TO PREVENT POSTTRAUMATIC OSTEOARTHRITIS IN PATIENTS SUSTAINING SEVERE ANKLE TRAUMA." The award has an initial performance period from August 15, 2025 to August 14, 2030. The research aims to investigate the use of...
- The Defense Health Agency awarded a $622,008 project grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on November 1, 2024, with a completion date of October 31, 2026, supports research on "The SAGA Complex as an Essential Regulator of Abnormal Transcription Through De Novo DNA Topology Interactions in Multiple Myeloma." This project grant aims to...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,924 Project Grant to the Trustees of Indiana University to support a 3-year research project titled "EARLY IMMUNOLOGIC PRECISION TYPING AT-RISK FRACTURES TO PREDICT NONUNION". The project aims to characterize the temporal immune/inflammatory biomarker profile in patients with open tibial fractures and develop a predictive model to guide decision-making for musculoskeletal...